V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20029346 | 20012506 | 1.61 | 62 | Neo-adjuvant (N) | null | 2015-04-15 | FEC + DOCETAXEL | N | N | 20103475 | FEC + DOCETAXEL |
| 20029347 | 20012507 | 1.59 | null | Adjuvant (A) | null | 2013-04-10 | FEC + DOCETAXEL | 99 | N | 20103485 | FEC + DOCETAXEL |
| 20029348 | 20012507 | 1.64 | 112 | Neo-adjuvant (N) | 2017-01-25 | 2017-02-03 | FEC 100 + DOCETAXEL | 02 | null | 20103485 | FEC + DOCETAXEL |
| 20029349 | 20012508 | 1.76 | 82.3 | Adjuvant (A) | 2016-07-07 | 2016-08-10 | FEC + DOCETAXEL | N | N | 20103496 | FEC + DOCETAXEL |
| 20029350 | 20012508 | 1.63 | 69.2 | Curative (C) | 2018-01-15 | 2018-01-25 | FEC 100 + DOCETAXEL | 02 | null | 20103496 | FEC + DOCETAXEL |
| 20029351 | 20012509 | 1.67 | 61.5 | Curative (C) | 2017-10-16 | 2017-11-07 | FEC 100 + DOCETAXEL | N | N | 20103509 | FEC + DOCETAXEL |
| 20029352 | 20012509 | null | null | Adjuvant (A) | null | 2018-01-12 | FEC + DOCETAXEL | N | N | 20103509 | FEC + DOCETAXEL |
| 20029353 | 20012509 | null | null | Adjuvant (A) | 2014-12-01 | 2014-12-16 | FEC 100 + DOCETAXEL | N | N | 20103509 | FEC + DOCETAXEL |
| 20029354 | 20012509 | 1.64 | 127 | Adjuvant (A) | 2013-10-13 | 2013-10-17 | FEC + DOCETAXEL | 2 | N | 20103509 | FEC + DOCETAXEL |
| 20029355 | 20012509 | 1.69 | 88 | Adjuvant (A) | 2016-07-03 | 2016-07-14 | FEC 100 + DOCETAXEL | null | null | 20103509 | FEC + DOCETAXEL |
| 20029356 | 20012510 | 1.63 | null | Adjuvant (A) | 2015-05-22 | 2015-05-22 | FEC + DOCETAXEL | N | N | 20103525 | FEC + DOCETAXEL |
| 20029357 | 20012510 | 1.55 | 94.2 | Adjuvant (A) | 2016-11-26 | 2016-11-27 | FEC + DOCETAXEL | 02 | N | 20103525 | FEC + DOCETAXEL |
| 20029358 | 20012510 | 1.55 | 66.05 | Adjuvant (A) | 2017-10-11 | 2017-10-11 | FEC 100 + DOCETAXEL | 2 | N | 20103525 | FEC + DOCETAXEL |
| 20029359 | 20012510 | null | 87.2 | Neo-adjuvant (N) | 2017-07-30 | 2017-08-05 | FEC + DOCETAXEL | N | N | 20103525 | FEC + DOCETAXEL |
| 20029360 | 20137951 | 1.57 | 75.6 | Neo-adjuvant (N) | 2015-03-01 | 2015-03-20 | FEC + DOCETAXEL | N | N | 20103537 | FEC + DOCETAXEL |
| 20029361 | 20012511 | 1.59 | 6 | Neo-adjuvant (N) | 2015-08-04 | 2015-08-20 | FEC 100 + DOCETAXEL | N | N | 20103545 | FEC + DOCETAXEL |
| 20029362 | 20012511 | 1.67 | 54.8 | Curative (C) | 2015-02-27 | 2015-03-01 | FEC + DOCETAXEL | 2 | N | 20103545 | FEC + DOCETAXEL |
| 20029363 | 20012512 | 1.7 | 73.6 | Palliative (P) | 2016-08-21 | 2016-08-28 | FEC + DOCETAXEL | N | N | 20103547 | FEC + DOCETAXEL |
| 20029364 | 20012512 | null | null | Neo-adjuvant (N) | null | 2014-07-07 | FEC 100 + DOCETAXEL | null | null | 20103547 | FEC + DOCETAXEL |
| 20029365 | 20012513 | 1.65 | 55 | Adjuvant (A) | 2017-08-29 | 2017-09-04 | FEC + DOCETAXEL | 02 | N | 20103556 | FEC + DOCETAXEL |
| 20029366 | 20012513 | 1.63 | 57.2 | Neo-adjuvant (N) | null | 2017-10-11 | FEC + DOCETAXEL | N | N | 20103556 | FEC + DOCETAXEL |
| 20029367 | 20012514 | null | null | Neo-adjuvant (N) | 2017-07-19 | 2017-08-08 | FEC + DOCETAXEL | null | N | 20103566 | FEC + DOCETAXEL |
| 20029368 | 20012514 | 1.74 | 76 | Neo-adjuvant (N) | 2014-06-29 | 2014-07-19 | FEC 100 + DOCETAXEL | N | N | 20103566 | FEC + DOCETAXEL |
| 20029369 | 20012515 | 1.62 | 95 | Adjuvant (A) | 2018-01-18 | 2018-02-02 | FEC + DOCETAXEL | 02 | N | 20103574 | FEC + DOCETAXEL |
| 20029370 | 20072525 | 1.55 | null | Adjuvant (A) | 2015-06-06 | 2015-07-01 | FEC + DOCETAXEL | 2 | null | 20103586 | FEC + DOCETAXEL |
| 20029371 | 20012516 | 1.59 | 107 | Adjuvant (A) | 2014-05-11 | 2014-05-23 | FEC + DOCETAXEL | 02 | N | 20103589 | FEC + DOCETAXEL |
| 20029372 | 20012516 | 1.62 | 86 | Adjuvant (A) | 2013-12-24 | 2013-12-28 | FEC 100 + DOCETAXEL | 2 | N | 20103589 | FEC + DOCETAXEL |
| 20029373 | 20012516 | 0 | 95.8 | Adjuvant (A) | 2017-11-13 | 2017-11-27 | FEC 100 + DOCETAXEL | 2 | N | 20103589 | FEC + DOCETAXEL |
| 20029374 | 20012516 | 1.59 | 85 | Adjuvant (A) | 2014-10-11 | 2014-10-18 | FEC + DOCETAXEL | 2 | N | 20103589 | FEC + DOCETAXEL |
| 20029375 | 20012517 | 1.61 | 48 | Adjuvant (A) | 2015-02-16 | 2015-02-18 | FEC + DOCETAXEL | 02 | N | 20103597 | FEC + DOCETAXEL |
| 20029376 | 20012518 | 1.62 | 93.9 | Neo-adjuvant (N) | 2016-09-07 | 2016-09-07 | FEC + DOCETAXEL | 02 | N | 20103604 | FEC + DOCETAXEL |
| 20029377 | 20012519 | 1.55 | 78 | Adjuvant (A) | 2017-01-29 | 2017-02-19 | FEC + DOCETAXEL | 02 | N | 20103609 | FEC + DOCETAXEL |
| 20029378 | 20012519 | 1.5 | 126 | Not known (9) | 2017-03-21 | 2017-03-24 | FEC + DOCETAXEL | 02 | N | 20103609 | FEC + DOCETAXEL |
| 20029379 | 20012520 | null | 66 | Adjuvant (A) | 2014-11-18 | 2015-01-01 | FEC + DOCETAXEL | Y | N | 20103612 | FEC + DOCETAXEL |
| 20029380 | 20012520 | null | 54.5 | Adjuvant (A) | null | 2015-05-13 | FEC + DOCETAXEL | null | null | 20103612 | FEC + DOCETAXEL |
| 20029381 | 20012521 | 1.55 | 85.1 | Adjuvant (A) | 2017-03-15 | 2017-04-04 | FEC + DOCETAXEL | 02 | Y | 20103616 | FEC + DOCETAXEL |
| 20029382 | 20012522 | 1.7 | 72.2 | Adjuvant (A) | 2016-11-17 | 2016-11-17 | FEC + DOCETAXEL | 2 | N | 20103618 | FEC + DOCETAXEL |
| 20029383 | 20012522 | 1.7 | 67 | Neo-adjuvant (N) | 2017-11-23 | 2017-11-23 | FEC 60 OR 75 + DOCETAXEL | 2 | N | 20103618 | FEC + DOCETAXEL |
| 20029384 | 20012522 | 1.76 | 78.9 | Adjuvant (A) | 2018-01-17 | 2018-01-18 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20103618 | FEC + DOCETAXEL |
| 20029385 | 20012523 | null | 62.6 | Adjuvant (A) | 2017-05-19 | 2017-06-09 | FEC + DOCETAXEL | N | N | 20103626 | FEC + DOCETAXEL |
| 20029386 | 20012523 | 1.7 | 92.4 | Adjuvant (A) | 2016-12-11 | 2016-12-14 | FEC + DOCETAXEL | 02 | N | 20103626 | FEC + DOCETAXEL |
| 20029387 | 20012524 | 1.65 | 83 | Adjuvant (A) | 2015-06-21 | 2015-06-21 | FEC + DOCETAXEL | 02 | N | 20103630 | FEC + DOCETAXEL |
| 20029388 | 20012524 | 1.58 | null | Adjuvant (A) | 2017-08-19 | 2017-09-02 | FEC + DOCETAXEL | N | N | 20103630 | FEC + DOCETAXEL |
| 20029389 | 20012525 | 1.64 | 124.95 | Palliative (P) | 2014-06-03 | 2014-06-23 | FEC + DOCETAXEL | N | N | 20103634 | FEC + DOCETAXEL |
| 20029390 | 20012525 | 1.78 | 80.4 | Neo-adjuvant (N) | 2015-02-21 | 2015-03-05 | FEC + DOCETAXEL | 02 | N | 20103634 | FEC + DOCETAXEL |
| 20029391 | 20012525 | 1.66 | 70 | Adjuvant (A) | 2013-05-29 | 2013-05-30 | FEC + DOCETAXEL | 2 | N | 20103634 | FEC + DOCETAXEL |
| 20029392 | 20128080 | null | null | Palliative (P) | null | 2015-03-13 | FEC + DOCETAXEL | null | null | 20103644 | FEC + DOCETAXEL |
| 20029393 | 20128080 | 1.75 | 75.8 | Curative (C) | 2016-10-02 | 2016-10-14 | FEC + DOCETAXEL | 2 | N | 20103644 | FEC + DOCETAXEL |
| 20029394 | 20128080 | 1.55 | 62.5 | Adjuvant (A) | 2017-05-31 | 2017-06-10 | FEC + DOCETAXEL | 02 | null | 20103644 | FEC + DOCETAXEL |
| 20029395 | 20128080 | null | 65.7 | Adjuvant (A) | 2014-12-23 | 2015-01-01 | FEC + DOCETAXEL | N | N | 20103644 | FEC + DOCETAXEL |